Please note: In 2003, the CTF updated its Grades of
Recommendations to include an "I Recommendation" for situations where
insufficient evidence exists to allow a recommendation to be made.
(Formerly, these situations were captured under a "C
Recommendation".) This change is not retroactive, and all
"C Recommendations" made prior to 2003 have not been
reevaluated in light of the new "I" recommendation grade. For a
discussion of these recommendation grades, please link to the 2003 article in
the Canadian Medical Association Journal here.
Prevention of Periodontal Disease
Prepared by Amid I. Ismail, BDS, MPH, DrPH, Department of Pediatric and
Community Dentistry, Dalhousie University, Donald, W. Lewis, DDS, DDPH,
MScD, FRCDC, Department of Community Dentistry, University of Toronto,
and Jennifer L. Dingle, MBA, former Canadian Task Force Coordinator (1990-1994).
Objective
To make recommendations about the prevention of gingivitis and periodontitis
in general and high-risk populations in Canada.
Burden of Suffering
Periodontal diseases are the most prevalent chronic diseases affecting
children, adolescents, adults, and the elderly. The most common type of
periodontal disease is gingivitis and its most common form is chronic plaque-associated
inflammation. In the most recent survey of American children and adolescents
60% of those examined had at least one tooth site with gingival bleeding.
The prevalence of gingival bleeding increases significantly until age 34
years when it reaches a plateau; overall, prevalence is 47-55%. Periodontitis
is highly prevalent, affecting 53% of 18-19 year-old American adults and
98% of individuals over 60 years of age. Risk factors for periodontitis
include cigarette smoking, non-insulin dependent diabetes and possibly
malocclusion and defective host defenses. In 1981, the estimated treatment
time required to manage all individuals with gingivitis and periodontitis
in the U.S., over a 4 year period, was 120 to 133 million treatment hours,
at a cost of U.S. $5 to $6 billion annually.
Options
Options for plaque and calculus control included (i) personal oral
hygiene (brushing, flossing); (ii) professional care (scaling, root planing);
(iii) antimicrobial agents such as oral rinses (chlorhexidine, Listerine
®, Plax ®, Scope ®, Cepacol ®) and antibiotics (tetracycline);
(iv) anti-calculus toothpastes; and (v) physician counselling.
Outcomes
Periodontitis and gingivitis (usually indicated by gingival bleeding).
Other outcomes were supragingival plaque, loss of periodontal attachment
level and adverse effects of manoeuvres.
Evidence
MEDLINE was searched from 1980 to 1993 using the keyword "periodontal
disease". Selected studies published before 1980 were also reviewed. Study
results were synthesized in table or graphic format only.
Values
The 13-member Task Force of experts in family medicine, geriatric medicine,
pediatrics, psychiatry and epidemiology used an evidence-based method for
evaluating the effectiveness of preventive health care interventions. Recommendations
were not based on cost-effectiveness of options. Patient preferences were
not discussed.
Background papers providing critical appraisal of the evidence and tentative
recommendations prepared by the chapter author were pre-circulated to the
members. Evidence for this topic was presented and deliberated upon in
1- to 2-day meetings, 2 to 3 times per year from January 1993 to June 1993.
Consensus was reached on final recommendations.
Benefits, Harms, and Costs
Unless otherwise specified, results are from RCTs.
Good evidence shows that supragingival plaque causes gingivitis and
effective plaque removal every 48 hours is associated with gingival health.
A 2-week clinical trial involving adults found that brushing twice a day
was associated with a 35% reduction in gingival bleeding, and that brushing
plus flossing resulted in a 67% reduction. A clinical trial involving school
children found brushing to be as effective as brushing plus flossing (p422).
No consistent evidence exists regarding the superiority of electric
toothbrushes over manual toothbrushes (422-23).
One RCT found that adults benefited from receiving 11 professional prophylaxes
over a 3 year period. This finding has limited generalizability because
of the intensity of care provided. Other RCTs reported that annual scaling
was as effective as more frequent care (p423).
Unsupervised use of chlorhexidine oral rinse for 6 months reduced supragingival
plaque and gingivitis more effectively than sanguinarine or Listerine ®.
Adverse effects included increased calculus formation, bad taste and staining
of teeth (p423). Listerine ® was effective in preventing gingivitis
when compared with placebo over 6 to 9 month periods. Adverse effects were
poor taste and a burning sensation in the mouth. No long term studies of
the effectiveness of unsupervised use of other over-the-counter oral rinses
exist (p424).
No studies of the effect of antibiotic prophylaxis have been conducted
because of potential side effects, and the potential development of resistant
bacterial strains and patient hypersensitivity (p424).
Anticalculus (anti-tartar) toothpastes prevent calcification of plaque.
Supragingival calculus was reduced by 32% to 35%. Potential adverse effects
are cheilitis and mucosal erythema; long term effects are unknown.
Cross-sectional and longitudinal studies confirm the association between
cigarette smoking and periodontitis. Smokeless tobacco is not associated
with severe periodontal destruction (421)
No studies exist on the effectiveness of physician counselling (p422)
or screening for periodontal disease.
Recommendations
Recommendation grade [A, B, C, D, E] and level of evidence
[I, II-1, II-2, II-3, III] are indicated after each recommendation. Citations
in support of individual recommendations are identified in the guideline
text.
-
There is fair evidence to recommend toothbrushing in adults and children
[B, I, III] and good evidence to recommend flossing in adults [A,
I]
to prevent gingivitis. There is poor evidence to include or exclude flossing
in children, but flossing is recommended to develop flossing skills and
habits [C, I]. Based on poor evidence, supervised toothbrushing
and flossing are recommended for patients with malocclusion, diabetes or
HIV infection [C, II-2].
-
There is fair evidence not to recommend electric toothbrush use for the
general population [D, I]. Based on poor evidence, use is recommended
for patients with limited dexterity [C, II-2].
-
There is fair evidence to recommend professional scaling and prophylaxis
depending on a patients periodontal disease status [B, I].
-
There is good evidence to recommend rinsing with 0.12% chlorhexidine twice
daily for patients who have difficulty cleaning their teeth (e.g., patients
with disability, cancer) [A, I].
-
There is fair evidence to recommend use of Listerine ® oral rinse for
patients with severe gingivitis [B, I]. There is fair evidence not
to use other over-the-counter oral rinses [D, no studies available].
-
There is good evidence not to recommend prophylactic antibiotic use [E,
no
studies available].
-
There is no evidence to recommend anticalculus toothpaste use for the general
population [C, I], and good evidence to recommend its use for patients
at high risk for calculus formation [B, I].
-
There is fair evidence to recommend smoking cessation [B, II-2].
-
There is insufficient evidence to evaluate screening for periodontal disease
by physicians, but screening is recommended in regions with no available
dental services [C, no studies].
Validation
This report was externally peer reviewed. The 1989 U.S. Preventive
Services Task Force recommendations (since updated) included regular professional
care visits, and counselling by primary care providers on regular brushing
and flossing and on tobacco use.
Sponsors
The Canadian Task Force on Preventive Health
Care developed this guideline with funding from Health Canada and the
Faculties of Dentistry at Dalhousie University and the University of Toronto.
Source Document
Ismail, A.I., Lewis, D.W., Dingle, J.L. Prevention of periodontal disease.
In: Canadian Task Force on the Periodic Health Examination. Canadian
Guide to Clinical Preventive Health Care. Ottawa: Health Canada,
1994; 420-431.